Researchers have concluded that siromilus stents offer a lower heart attack risk for patients than bare metal stents or paclitaxel. Mortality risks linked to drug-eluting stents and bare-metal stents for coronary revascularization have generally been fairly similar, the researchers explain. You can read about their conclusions in a report in The Lancet, issued this week.
Siromilus Stents Offer Lower Heart Attack Risk Than Bare Metal Stents Or Paclitaxel
0 comments :
Post a Comment